Furthermore, some studies reported the important role of the phosphoinositide3-kinase (PI3K)/AKT/mammalian target of the rapamycin pathway (PI3K/AKT/mTOR pathway) in GC patients [101]. Here, AKT1 is linked to gastric cancer.